Literature DB >> 22078927

Cancer nanomedicines targeting tumor extracellular pH.

Li Tian1, You Han Bae.   

Abstract

Tumors have been a highlight in the research of nanomedicine for decades. Despite all the efforts in the decoration of the nano systems, tumor specific targeting is still an issue due to the heterogeneous nature of tumors. Hypoxia is frequently observed in solid tumors. The consequent acidification of tumor extracellular matrices may bring new insight to tumor targeting. In this review, we present the polymeric nano systems that target tumor extracellular pH (pH(e)).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078927      PMCID: PMC3345308          DOI: 10.1016/j.colsurfb.2011.10.039

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  109 in total

1.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

2.  Temperature-sensitive chitosan-poly(N-isopropylacrylamide) interpenetrated networks with enhanced loading capacity and controlled release properties.

Authors:  Carmen Alvarez-Lorenzo; Angel Concheiro; Alexander S Dubovik; Natalia V Grinberg; Tatiana V Burova; Valerij Ya Grinberg
Journal:  J Control Release       Date:  2005-02-16       Impact factor: 9.776

Review 3.  The hypoxia-inducible factor and tumor progression along the angiogenic pathway.

Authors:  M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Int Rev Cytol       Date:  2005

4.  Understanding the tumor metabolic phenotype in the genomic era.

Authors:  M Stubbs; C L Bashford; J R Griffiths
Journal:  Curr Mol Med       Date:  2003-02       Impact factor: 2.222

5.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

6.  The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts.

Authors:  T W Grunt; A Lametschwandtner; O Staindl
Journal:  Microvasc Res       Date:  1985-05       Impact factor: 3.514

Review 7.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

Authors:  J G Klijn; P M Berns; P I Schmitz; J A Foekens
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

8.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

Authors:  R D Oberhaensli; D Hilton-Jones; P J Bore; L J Hands; R P Rampling; G K Radda
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  23 in total

1.  Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.

Authors:  Lingli Zhou; Liu Yang; Chulei Yang; Yi Liu; Qiuyue Chen; Wenli Pan; Qing Cai; Lifeng Luo; Lu Liu; Shan Jiang; Haibing He; Yu Zhang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-05-23       Impact factor: 4.200

Review 2.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

Review 3.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

4.  Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.

Authors:  Zhengxiong Li; Linlin Zhang; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

5.  Promoting antitumor activities of hydroxycamptothecin by encapsulation into acid-labile nanoparticles using electrospraying.

Authors:  Xiaoming Luo; Guoqing Jia; Haixing Song; Chaoyu Liu; Guannan Wu; Xiaohong Li
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

Review 6.  Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

Authors:  Robert J Gillies; Daniel Verduzco; Robert A Gatenby
Journal:  Nat Rev Cancer       Date:  2012-06-14       Impact factor: 60.716

7.  Comparison of two methods for tumour-targeting peptide modification of liposomes.

Authors:  Shi-Qi Huang; Han-Ming Zhang; Yi-Cong Zhang; Lu-Yao Wang; Zhi-Rong Zhang; Ling Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-10-21       Impact factor: 7.169

Review 8.  Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.

Authors:  Akhil Patel; Shilpa Sant
Journal:  Biotechnol Adv       Date:  2016-04-30       Impact factor: 14.227

9.  pH-responsive nano carriers for doxorubicin delivery.

Authors:  Shahla Bagherifam; Frode Miltzow Skjeldal; Gareth Griffiths; Gunhild M Mælandsmo; Olav Engebråten; Bo Nyström; Vasif Hasirci; Nesrin Hasirci
Journal:  Pharm Res       Date:  2014-10-07       Impact factor: 4.200

Review 10.  pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.

Authors:  Mahdi Karimi; Masoud Eslami; Parham Sahandi-Zangabad; Fereshteh Mirab; Negar Farajisafiloo; Zahra Shafaei; Deepanjan Ghosh; Mahnaz Bozorgomid; Fariba Dashkhaneh; Michael R Hamblin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.